KCNN4 and cancer: Given that ICGs are a feasible indicator associated with efficacy of immunotherapy (Larkin et al., 2015; Chen and Mellman, 2017), we further performed correlation analysis between ICGs and KCNN4 expression in pan-cancer subtypes (Figure 7C).